LabGenius Therapeutics will present preclinical data for LGTX-101, its AI-designed Nectin-4 x CD3 T-cell engager, at AACR 2026 in San Diego.
The study successfully correlated specific compounds with sensory profiles like sweetness and flavor, offering valuable insights to improve predictive models and guide future strawberry breeding ...
BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced it will ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
Quantitative finance continues to debate the reliability and limits of model-driven investment strategies. Read more here.
March 17, 2026. Enara Bio, a pioneer in Dark Antigen® discovery and bispecific T cell engager innovation, today announced new ...
Objective: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical deci ...
Long-term registry-linked analysis of nearly 15,000 adults shows that antibiotic use is associated with persistent changes in gut microbiome diversity and composition for up to 4–8 years. These ...
A new study has revealed that there is a causal relationship between increased air pollution and a rise in outpatient visits for chronic rhinitis. Beyond mere association, the analysis provides robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results